Optimization of Orally Bioavailable PI3Kδ Inhibitors and Identification of Vps34 as a key off-target activity.
暂无分享，去创建一个
P. Grandi | Christina Rau | M. Bantscheff | G. Bergamini | M. Convery | P. Rowland | Birgit Duempelfeld | D. Mallett | Chris D. Edwards | A. Amour | Friedrich B M Reinhard | N. Barton | A. C. Maxwell | K. Down | E. Hessel | Sophie M. Bertrand | J. Rowedder | S. Keeling | Z. Henley | J. N. Hamblin | Daniel A. Thomas | M. Price | P. Gore | S. Livia | Jonathan A. Taylor | Christina E. Rau | P. M. Gore | Kenneth Down | A. Maxwell